tiprankstipranks
Advertisement
Advertisement
PremiumRatingsBuy Rating Reaffirmed on Seaport’s Advancing CNS Pipeline; $35 Price Target Maintained
1M ago
Seaport Therapeutics reports Q1 EPS ($10.34) vs. ($5.65) last year
Premium
The Fly
Seaport Therapeutics reports Q1 EPS ($10.34) vs. ($5.65) last year
1M ago
Seaport Therapeutics sees cash runway into 2029
Premium
The Fly
Seaport Therapeutics sees cash runway into 2029
1M ago
Seaport Therapeutics initiated with a Buy at Stifel
PremiumThe FlySeaport Therapeutics initiated with a Buy at Stifel
2M ago
Seaport Therapeutics initiated with an Overweight at JPMorgan
Premium
The Fly
Seaport Therapeutics initiated with an Overweight at JPMorgan
2M ago
Seaport Therapeutics initiated with Early-Stage Biotech at Goldman Sachs
Premium
The Fly
Seaport Therapeutics initiated with Early-Stage Biotech at Goldman Sachs
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100